GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Awakn Life Sciences Corp (XCNQ:AWKN) » Definitions » Gross Margin %

Awakn Life Sciences (XCNQ:AWKN) Gross Margin % : 0.00% (As of Jan. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Awakn Life Sciences Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Awakn Life Sciences's Gross Profit for the three months ended in Jan. 2024 was C$0.02 Mil. Awakn Life Sciences's Revenue for the three months ended in Jan. 2024 was C$0.02 Mil. Therefore, Awakn Life Sciences's Gross Margin % for the quarter that ended in Jan. 2024 was 0.00%. If there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.


The historical rank and industry rank for Awakn Life Sciences's Gross Margin % or its related term are showing as below:

XCNQ:AWKN' s Gross Margin % Range Over the Past 10 Years
Min: -117.37   Med: -117.37   Max: -60.31
Current: -60.31


During the past 4 years, the highest Gross Margin % of Awakn Life Sciences was -60.31%. The lowest was -117.37%. And the median was -117.37%.

XCNQ:AWKN's Gross Margin % is ranked worse than
95.33% of 749 companies
in the Biotechnology industry
Industry Median: 60.9 vs XCNQ:AWKN: -60.31

Awakn Life Sciences had a gross margin of N/A% for the quarter that ended in Jan. 2024 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Awakn Life Sciences was 0.00% per year.


Awakn Life Sciences Gross Margin % Historical Data

The historical data trend for Awakn Life Sciences's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Awakn Life Sciences Gross Margin % Chart

Awakn Life Sciences Annual Data
Trend Jan21 Jan22 Jan23 Jan24
Gross Margin %
- -117.37 - -

Awakn Life Sciences Quarterly Data
Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -84.15 - - -

Competitive Comparison of Awakn Life Sciences's Gross Margin %

For the Biotechnology subindustry, Awakn Life Sciences's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Awakn Life Sciences's Gross Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Awakn Life Sciences's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Awakn Life Sciences's Gross Margin % falls into.



Awakn Life Sciences Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

Awakn Life Sciences's Gross Margin for the fiscal year that ended in Jan. 2024 is calculated as

Gross Margin % (A: Jan. 2024 )=Gross Profit (A: Jan. 2024 ) / Revenue (A: Jan. 2024 )
=0.1 / 0.087
=(Revenue - Cost of Goods Sold) / Revenue
=(0.087 - 0) / 0.087
=N/A %

Awakn Life Sciences's Gross Margin for the quarter that ended in Jan. 2024 is calculated as


Gross Margin % (Q: Jan. 2024 )=Gross Profit (Q: Jan. 2024 ) / Revenue (Q: Jan. 2024 )
=0 / 0.022
=(Revenue - Cost of Goods Sold) / Revenue
=(0.022 - 0) / 0.022
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Awakn Life Sciences  (XCNQ:AWKN) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Awakn Life Sciences had a gross margin of N/A% for the quarter that ended in Jan. 2024 => No sustainable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Awakn Life Sciences Gross Margin % Related Terms

Thank you for viewing the detailed overview of Awakn Life Sciences's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Awakn Life Sciences (XCNQ:AWKN) Business Description

Traded in Other Exchanges
Address
301?217 Queen Street West, Toronto, ON, CAN, M5V 0R2
Awakn Life Sciences Corp is a clinical-stage biotechnology company intended to develop therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder. The Company focuses on Alcohol Use Disorder (AUD), a condition affecting the people in the US and key international markets and many people globally for which the current standard of care is inadequate, enabling to provide breakthrough therapeutics to addiction sufferers in desperate need.

Awakn Life Sciences (XCNQ:AWKN) Headlines

No Headlines